CMS Open Payments · Program Year 2024
Asensus Surgical, Inc.
Asensus Surgical, Inc. reported $235,866.62 across General Payments, Research, and Ownership to 294 physicians and teaching hospitals across 295 transactions.
- $235.9K Above-median payer
- All-tracks total
- 295 Above-median volume
- Transactions
- 294 Above-median reach
- Recipients
- −$61.8K
- General Payments vs PY2023
Asensus Surgical, Inc. reported $235,866.62 across all CMS Open Payments tracks (General + Research + Ownership) to 294 physicians and teaching hospitals in Program Year 2024 - ranking #958 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $207,130.41, averaging $802.27 per recipient.
How Asensus Surgical, Inc.'s $235.9K all-tracks total breaks down
Asensus Surgical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
12/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer asensus-surgical-inc Asensus Surgical, Inc.
$235.9K · #958/1,925 · 0.0% industry · PY2024
- TOT $235.9K
- RANK #958
- SHARE 0.0%
- TXN 295
- RCP 294
- CAT 6
- GEN $207.1K
- ΔGEN −$61.8K
- TOP1 21.1%
- PY 2024
Volume peers
Nearest volume peer: Synthes USA Products LLC ($235.8K)
Asensus Surgical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Asensus Surgical, Inc.'s CMS-reported General Payments decreased by $61.8K (−23.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ASENSUS SURGICAL, INC.PY2023: ASENSUS SURGICAL, INC.PY2024: Asensus Surgical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $268,913.22
- PY2024
- $207,130.41
What the Data Shows for Asensus Surgical, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Asensus Surgical, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Consulting Fee" leads the 6-category general-payment breakdown below at $94.6K (45.7% of General Payments, 55 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Asensus Surgical, Inc. made 6 types of general payments. "Consulting Fee" is the largest category at $94.6K, 45.7% of General Payments.
Asensus Surgical, Inc. reports 6 general-payment categories - the top three are Consulting Fee (45.7%), Compensation for Services Other Than Consulting (20.3%), and Space Rental or Facility Fees (14.0%). The remaining 3 categories make up 20.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Asensus Surgical, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $94.6K | 55 | 45.7% |
| Compensation for Services Other Than Consulting | $42.0K | 3 | 20.3% |
| Space Rental or Facility Fees | $28.9K | 17 | 14.0% |
| Travel and Lodging | $28.0K | 65 | 13.5% |
| Education | $6.8K | 2 | 3.3% |
| Food and Beverage | $6.8K | 152 | 3.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $142,249.13 (68.7%) of $207,130.41 in this company's General Payments records across 93 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Asensus Surgical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Elizabeth Kwo
$43,700.95 across 4 reported transactions
- 2
Adventhealth Orlando
$33,225.05 across 18 reported transactions
- 3
Amit Trivedi
$24,689.42 across 20 reported transactions
- 4
Francesco Bianco
$23,813.53 across 27 reported transactions
- 5
Steven Rothenberg
$16,820.18 across 27 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Asensus Surgical, Inc.'s spend rank (#958 of 1,925, top 50% by spend) and concentration rank (#969 of 1,838, bottom 47% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Hollister Incorporated : $45.3K total payments, HHI 1167
- Kamada Ltd. : $83.4K total payments, HHI 1166
- Pulpdent Corporation : $80.0K total payments, HHI 1162
- Optos, Inc. : $585.3K total payments, HHI 1153
- HemoSonics LLC : $100.7K total payments, HHI 1152
- Intercept Pharmaceuticals, Inc. : $2.8M total payments, HHI 1149
- Asensus Surgical, Inc. (this company) : $207.1K total payments, HHI 1147
- Alcresta Therapeutics, Inc. : $170.2K total payments, HHI 1141
- Pathway Medical Partners, LLC : $66.0K total payments, HHI 1140
- Visionix USA, Inc : $108.9K total payments, HHI 1138
- Anika Therapeutics, Inc. : $1.1M total payments, HHI 1135
- Woven Orthopedic Technologies, LLC : $1.2K total payments, HHI 1134
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Asensus Surgical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Asensus Surgical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Asensus Surgical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Stability Biologics, LLC
Fuse Medical, Inc.
MiRus, LLC
I/O Urology Corp.
Ambu Inc.
Put this to use
Asensus Surgical, Inc. ranks #958 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Asensus Surgical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.